Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jan. 28, 2024	Jan. 29, 2023
Cash flows from operating activities:
Net income	$ 39,082	$ 28,950
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,702	19,105
Share-based compensation	2,573	1,821
Changes in assets and liabilities:
Accounts receivable	(2,906)	(7,565)
Inventories	409	1,705
Other current assets	(2,844)	(13,060)
Accounts payable, accrued liabilities, and other	(15,508)	(3,276)
Net cash provided by operating activities	41,508	27,680
Cash flows from investing activities:
Purchases of property, plant and equipment	(43,314)	(31,097)
Purchases of available-for-sale debt securities	(2,436)	0
Proceeds from maturities of available-for-sale debt securities	2,500	0
Government incentives	1,091	1,014
Other	(56)	(87)
Net cash used in investing activities	(42,215)	(30,170)
Cash flows from financing activities:
Repayments of debt	(1,194)	(9,218)
Proceeds from share-based arrangements	936	672
Net settlements of restricted stock awards	(2,613)	(1,168)
Net cash used in financing activities	(2,871)	(9,714)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	13,026	27,499
Net increase (decrease) in cash, cash equivalents, and restricted cash	9,448	15,295
Cash, cash equivalents, and restricted cash at beginning of period	501,867	322,409
Cash, cash equivalents, and restricted cash at end of period	511,315	337,704
Less: Ending restricted cash	2,797	2,912
Cash and cash equivalents at end of period	508,518	334,792
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased during the period	$ 1,628	$ 12,031